Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
84.61
+1.37 (1.65%)
At close: Nov 14, 2025, 4:00 PM EST
83.89
-0.72 (-0.85%)
After-hours: Nov 14, 2025, 7:54 PM EST
Protagonist Therapeutics Employees
Protagonist Therapeutics had 126 employees as of December 31, 2024. The number of employees increased by 14 or 12.50% compared to the previous year.
Employees
126
Change (1Y)
14
Growth (1Y)
12.50%
Revenue / Employee
$1,660,452
Profits / Employee
$364,357
Market Cap
5.29B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 126 | 14 | 12.50% |
| Dec 31, 2023 | 112 | 7 | 6.67% |
| Dec 31, 2022 | 105 | -13 | -11.02% |
| Dec 31, 2021 | 118 | 39 | 49.37% |
| Dec 31, 2020 | 79 | 6 | 8.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PTGX News
- 9 days ago - Protagonist Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Accesswire
- 12 days ago - Protagonist Therapeutics Announces Oral and Poster Presentations on Rusfertide at the 67th Annual ASH Meeting - Accesswire
- 4 weeks ago - Johnson & Johnson To Acquire Protagonist? It'd Be A Good Deal To Make - Seeking Alpha
- 5 weeks ago - Johnson & Johnson In Talks To Acquire Protagonist Therapeutics: Report - Benzinga
- 5 weeks ago - Johnson & Johnson in talks to acquire Protagonist Therapeutics, WSJ reports - Reuters
- 5 weeks ago - Johnson & Johnson in Talks to Buy Protagonist Therapeutics - WSJ
- 2 months ago - Protagonist Therapeutics, Inc. (PTGX) Presents At H.C. Wainwright 27th Annual Global Investment Conference Transcript - Seeking Alpha
- 2 months ago - Protagonist Therapeutics, Inc. (PTGX) Presents At Citi's Biopharma Back To School Conference Transcript - Seeking Alpha